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Abstract
Introduction. Health-related quality of life (HRQoL) after pacemaker (PM) implantation has been studied according to 
stimulation mode and indications, however these do not fully explain HRQoL changes. Aim of the study is to evaluate 
other factors.
Materials and methods. Single-center, prospective, observational study on 101 adult PM-recipients, with no periproce-
dural complications was performed. The study group was surveyed twice: periprocedural and 18 month follow-up (FU). 
Nottingham Health Profile to evaluate general HRQoL was performed. 83 participants completed full study protocol. 
Comparative analysis (periprocedural vs. end-of-FU) was performed to measure relationship between HRQoL-change 
and gender, place of residence, disability level, physical activity, level of care and support, BMI, diet, percentage of atrial 
and ventricular pacing (Ap&Vp), symptoms associated with rhythm and conduction disorders, severity of coronary heart 
disease and heart failure.
Results. Total HRQoL improvement occurred for the rural residents, obese and Vp > 79%. The study group improved 
significantly in two HRQoL domains: emotional reactions (E.R.) and sleep disorders (S.D.). Analyzing specific HRQoL do-
mains (energy, pain, E.R.S.D. social alienation, movement limitations) improved patients are: female, self-mobile, high 
level of care and support, eating habits — changers, without syncope and angina symptoms. Age and body mass index 
(BMI) were identified as factors changing HRQoL-improving domain.
Conclusions. The improvement of HRQoL after PM implantation seems to be mainly related to S.D. and E.R. Important 
factors influencing HRQoL change are: place of residence, BMI and Vp. This impact of PM implantation on HRQoL re-
quires further study
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Introduction
Increasingly more often we depart from purely biological 
approach to human health and assume a multifaceted 
point of view, where particular attention is focused on 
patient’s emotions, wellbeing and everyday functioning. 
Health defined in these terms may be considered a fun-
damental determinant of the health-related quality of life 
(HRQoL) [1–3].
While numerous studies have been performed in 
patients with implanted pacemakers with regard to the 
stimulation mode and indications for pacing, little is known 
about other aspects influencing the HRQoL of patients who 
require constant cardiac pacing [1–9]. This study focuses 
on search for those factors.
Material and methods
The study included 101 consecutive adult patients (46 men, 
55 women) aged 42 to 93 years (mean age 74.3 years) 
who had been admitted to the Cardiology Department of 
the 2nd Provincial Hospital in Rzeszow. Patients underwent 
implantation of a cardiac pacemaker according to the cur-
rent ESC guidelines. Procedures were free of complications 
and involved placement of an endocavitary electrode in the 
right ventricular apex and/or left atrial auricle.
Exclusion criteria were as follows:
 — mental disorders leading to non-compliance;
 — difficulties communicating (significant hearing impair-
ment, severe psychosomatic disorder);
Table 1. A compilation of the number of cardiac pacemaker types together with indications for implantation in study group A
Indications for implantation Pacemaker type
AAI VVI VDD DDD
Predominant heart rhythm: sinus rhythm
SSS 6 – – 33
AVB – 5* 15 13
SSS + AVB – – – 6
Trifascicular block accompanied by MAS – – – 1
Predominant heart rhythm: atrial fibrillation or flutter
Bradyarrhythmia – 22 – –
Total 6 27 15 53
Table 2. Study group characteristics depending on age, sex, place of residence and education*
Women Men Total
N (%)
Study group 55 (54.5%) 46 (45.5%) 101 (100.0%)
Place of residence:
• rural
• municipal
36 (35.6%)
19 (18.8%)
21(20.8%)
25 (24.8%)
57 (56.4%)
44 (43.6%)
Education:
• incomplete primary
• primary
• vocational
• secondary
• tertiary
• no data
9 (8.9%)
31 (30.7%)
7 (6.9%)
6 (5.9%)
1 (1.0%)
1 (1.0%)
1 (1.0%)
15 (14.9%)
11 (10.9%)
10 (9.9%)
7 (6.9%)
2 (2.0%)
10 (9.9%)
46 (45.5%)
18 (17.8%)
16 (15.8%)
8 (7.9%)
3 (3.0%)
Age M (SD), (min–max)
76.0 (8.04), (53–93) 72.3 (10.81), (42–89) 74.3 (9.53), (4–93)
*Due to group characteristics, percentage values are presented for the whole group; N — number; M — mean; SD — standard deviation
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 — recently diagnosed illness that is not directly associa-
ted with arrhythmia or conduction disturbances, but 
might impact HRQoL:
• unstable angina,
• acute myocardial infarction,
• coronary revascularization during the last 3 months;
 — acute stroke
 — predicted survival < 1.5 years
 — active cancer;
 — advanced heart failure (New York Heart Association 
[NYHA] III or IV);
 — lack of patient’s consent to participation in the study
Table 1 presents the types of implanted cardiac pa-
cemakers and indications for their implantation. Table 
2–4 present the characteristics of the study group.
After implantation, the pacemaker was programmed 
depending on clinical characteristics of a patient, i.a. by 
activating algorithms that reduce ventricular stimulation, 
and the patient was followed up for 1.5 years with regular 
outpatient visits (Figure 1).
Follow-up schedule could be modified as needed. Pa-
tients were free to choose a physician in general practice 
and specialist outpatient clinic. The attending physician 
was not informed of the follow-up and was free to make 
decisions regarding optimal pharmacotherapy and pace-
maker settings.
Patients filled out two surveys at the beginning and at 
the end of follow-up: our own questionnaire and Notting-
ham Health Profile (NHP) assessing HRQoL.
All comparative analyses (evaluation at the time of 
the procedure vs. at the end of follow-up) were performed 
on a group of 83 patients who completed the necessary 
questionnaires twice (Figures 1, 2).
Acquired data were used to analyze the change in 
HRQoL after pacemaker implantation and to evaluate the 
relationship between observed changes and sex, age, 
place of residence, level of disability, level of care and 
Table 3. Study group characteristics depending on subjective per-
ception of disability, physical activity, as well as level of care and 
support in everyday life
Patient characteristics N Percentage (%)
Level of disability
Bedbound 1 1.0
Sitting up 3 3.1
Walking with aid 16 16.3
Walking independently 78 79.6
Total 98 100.0
Level of physical activity
Normal 70 71.4
Slightly limited 17 17.3
Significantly limited 11 11.2
Total 98 100.0
Level of care and support
High 76 80.0
Moderate 12 12.6
Low 7 7.4
Total 95 100.0
N — number of patients
Table 4. Study group characteristics depending on body mass 
index (BMI)
BMI [kg/m2] N Percentage (%)
≤ 18 — underweight
18–25 — normal body mass
25–30 — overweight
≥ 30 — obesity
0
24
33
41
0.0
24.5
33.7
41.8
N — number of patients
Figure 1. Timetable of follow-up visits and questionnaire studies
Outpatient follow-up visits
1,5 years (follow-up period)
 
 
Discharge 7–14 days 1 month 3 months Every 6 months
Second evaluation (83 patients)First evaluation (101 patients) 
Questionnaire studies
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social support, BMI, physical activity, diet, percentage of 
ventricular and atrial stimulation, symptoms associated 
with arrhythmia and conduction disturbances, as well as 
the severity of ischemic heart disease and heart failure.
SPSSv.21.0 software for Windows was used to conduct 
the statistical analysis of the acquired material. After che-
cking for normality of distribution we employed statistical 
significance (mainly parametric) tests: Student’s t-test 
for dependent variables, ANOVA analysis of variance for 
more than two groups, Student’s t-test for independent 
variables, Wilcoxon’s test, Kruskal-Wallis test, Pearson’s 
R correlation coefficient, and Spearman’s Rho.
Beside significance analysis, we also determined (only 
for statistically significant tests) the effect size — so-called 
Cohen’s d for independent variables and Hedges g for 
dependent variables. Value below 0.2 may be considered 
statistically insignificant, effect size between 0.2 and 
0.49 corresponds to a small change, 0.5–0.79 — inter-
mediate, and above 0.8 — large (strong effect).
Changes in HRQoL are presented as differences of 
mean measurements performed with an NHP question-
naire for consecutive HRQoL domains, according to the 
following equation:
difference in means (X) = (mean value measured in pe-
rioperative period) – (mean value measured at the end 
of follow-up)
where: X > 0 signifies improvement in HRQoL, and 
X < 0 — worsening of HRQoL.
We checked whether and how selected factors influ-
ence change in HRQoL.
Results
The following results were obtained (Table 5). It was shown 
in the study group that improvement in HRQoL after pace-
maker implantation involves mainly sleep disorders (S.D.) 
and emotional reactions (E.R.).
We demonstrated a relationship between change in 
HRQoL and place of residence, BMI, and percentage of 
ventricular stimulation.
Also, significant changes in specific HRQoL domains 
were shown depending on sex, level of disability, physical 
activity, social care and support, change of nutritional 
habits after the procedure, and symptoms associated 
with arrhythmia and conduction disorders, as well as with 
symptoms of angina.
Moreover, age, BMI, level of physical activity and NYHA 
class were identified as parameters influencing the HRQoL 
domain that changed after the procedure.
Discussion
Numerous clinical studies analyzed the HRQoL of patients 
subject to constant cardiac pacing [4–9, 10–16].
Improvement in HRQoL after pacemaker implantation 
was demonstrated, i.a. in PASE [4], CTOPP [5], and FOLLO-
WPACE [17] trials and its relationship with the stimulation 
mode was disproven in those studies [4, 5, 18] even when 
indications for pacing (atrioventricular block vs. SSS) were 
taken into consideration [6]. However, opposite results 
were also reported [4, 19, 20]. In the face of such a large 
number of studies examining the above-mentioned asso-
ciations, our study focused on search for factors other than 
stimulation mode and indications for pacing that might 
influence HRQoL after pacemaker implantation.
Such studies are rare. FOLLOWPACE was the largest 
study of this kind, showing that improvement in HRQoL 
depends mainly on periprocedural HRQoL, patient age, 
cardiological comorbidities, and atrial fibrillation with 
bradycardia as an indication for cardiac pacing.
In the above study, factors that might potentially modu-
late HRQoL were selected and their true impact on HRQoL 
was examined after pacemaker implantation. We assumed 
similar approach in our own study [21], demonstrating an 
association between change in HRQoL after pacemaker 
Figure 2. Flowchart of questionnaire studies
101 patients enrolled in the study
18 did not fill out the final questionnaire due to 83 persons completed the full protocol
Death — 6 patients
Difficulties communicating caused by stroke — 2 patients
Difficulties communicating due to progressive dementia — 2 patients
Lack of consent to the final questionnaire at the end of follow-up — 8 patients
5www.journals.viamedica.pl/folia_cardiologica
Marcin Kostkiewicz et al., QoL after pacemaker implantation. Changes and factors
Table 5. Results
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implantation with place of residence, patient BMI and 
percentage of ventricular pacing.
Moreover, a detailed analysis of the study group sho-
wed that patients characterized by: female sex, residence 
in rural areas, ability to move independently, high level of 
care and social support, obesity, change in nutritional ha-
bits after the procedure, high percentage of cardiac pacing, 
symptoms of arrhythmia and conduction disorders other 
than syncope, and absence of angina symptoms, gain gre-
ater benefit with regard to specific HRQoL domains (energy, 
pain, E.R., S.D., social alienation, limitation of mobility).
Moreover, age and BMI were identified as factors influ-
encing the HRQoL domain that changes after implantation.
Below, we discuss all of the above-mentioned factors 
and their association with change in HRQoL after pace-
maker implantation.
High percentage of ventricular stimulation, obesity, 
and living in rural areas as main factors determining impro-
vement in HRQoL after cardiac pacemaker implantation.
Percentage of ventricular stimulation. Percentage of 
stimulated atrial (Ap) and ventricular (Vp) QRS complexes 
derives from the condition of pacemaker and conduction 
system and cardiac pacemaker mode.
Few authors report the percentage of atrial and ven-
tricular stimulation while discussing the results of their 
studies in patients after cardiac pacemaker implantation. 
There is no benefit in providing this information in the 
absence of data on pacemaker settings, as it cannot be 
determined whether the observed stimulation rate results 
from pacemaker’s settings or the disease itself. Authors 
of the CTOPP [5] indicate that pacemaker dependency 
(defined as HR < 50/min), which might potentially result 
in higher percentage of stimulated QRS complexes, does 
not in fact lead to statistically significant differences in 
HRQoL between patients with different stimulation mo-
des. In the analysis performed by Gribbin et al. [6] mean 
percentage of stimulated QRS complexes amounted to 
64%. Authors reported also that 25% of patients presented 
with 100% Vp and 5% did not require pacing at all. In this 
study there was no association between Vp and HRQoL 
after pacemaker implantation. Hemel et al. [22] came to 
similar conclusions in their study, which demonstrated 
no association between percentage of QRS complexes 
generated at the preset stimulation rate (DDDR mode) and 
HRQoL. Interpretation of the results of above clinical trials 
regarding lack of impact of percentage of Vp on HRQoL is 
only seemingly straight-forward. It is generally known that 
manufacturers of cardiac pacemakers make their best 
effort to introduce more modern and increasingly effective 
algorithms to avoid unnecessary Vp. In short, there is little 
data on the influence of implantable pacemaker mode and 
the condition of physiological pacemaker and conduction 
system on the percentage of Vp.
It seems that the results of this study should be in-
terpreted in this context. It showed positive correlation 
between percentage of Vp and improvement in HRQoL as 
well as a statistically significant change in HRQoL in the 
group of patients with percentage of Vp exceeding 79%. 
The improvement involved the following domains: E.R. and 
S.D. (P < 0.01), and was not observed among patients with 
lower stimulation rates.
Only statistically insignificant results were obtained for 
Ap (not included in the results table).
Obesity. The analyses of studies unrelated to pacema-
ker implantation showed that obesity negatively affects 
HRQoL by influencing physical capacity, sleep quality, 
mood, sexual life, ability to perform social roles and in-
teractions [23].
No analyses on the change in HRQoL depending on the 
value of BMI have been performed to date.
In our study group we analyzed change in HRQoL 
among patients with normal BMI, overweight and obese. 
BMI influenced the HRQoL domain affected by the great-
est change. Among patients with normal BMI the highest 
improvement was noted with regard to S.D. (g = 1.2). This 
change was less pronounced (g = 0.36), yet statistically 
significant (p < 0.05) among overweight patients. No sta-
tistically significant improvement in this domain was seen 
in the obese patients, although the observed change ap-
proached borderline statistical significance. There was, 
however, a statistically significant improvement with regard 
to pain and emotional reactions. It might be related to 
obstructive sleep apnea, the severity of which depends on 
BMI and significantly impairs the quality of sleep.
Living in rural areas. Different HRQoL change profiles 
were demonstrated for residents of rural vs. municipal 
areas. Patients living in rural regions gained clear benefit 
with regard to HRQoL following pacemaker implantation. 
Significantly better results were obtained for pain, E.R. and 
S.D. Residents of municipal areas experienced negative 
changes to their HRQoL after pacemaker implantation 
that included significant worsening of mobility and a trend 
toward greater perception of pain.
How should we interpret changes in HRQoL depending 
on the place of residence?
It appears that these changes might be related to 
a specific demographic status of the Sub-Carpathian 
region, which is dominated by small, agricultural settle-
ments remote from large municipal agglomerations. 
Consequently, their inhabitants have limited access to 
specialist healthcare. Possibly, the effects of pacemaker 
implantation observed in residents of rural areas might 
be augmented due to compulsory visits to cardiology 
outpatient clinics required for pacemaker control result-
ing in better care for other healthcare issues, as well as 
due to improved level of family support. The results of 
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this analysis were somewhat surprising and will require 
further investigation.
Sex, age, NYHA class, level of disability, physical activ-
ity, social care and support, change in nutritional habits 
after implantation and symptoms associated with arrhyth-
mia and conduction disorders, as well as the absence of 
symptoms of angina as factors influencing improvement 
in HRQoL with regard to S.D. and E.R.
Sex. Some studies [6, 18, 24] report an association 
between female sex and poorer HRQoL after pacemaker 
implantation; however, other study [19] did not report 
this relationship. There were no analyses showing worse 
HRQoL in men.
However, current analysis pertained to change in 
HRQoL after the procedure, not to its absolute levels. For 
the first time statistically significant results were demon-
strated with regard to: significant improvement in the E.R. 
domain of HRQoL for females only, improvement in sleep 
quality in both sexes (greater effect in men).
Age. Literature data is equivocal: some researchers 
demonstrate less improvement in HRQoL after pacemaker 
implantation with age, while others show no differences 
in HRQoL levels among older and younger patients [6, 
19, 20, 24].
The analysis of HRQoL results in our study group de-
monstrated improvement in sleep quality among patients 
aged 70 to 75 years and in emotional reactions among 
patients over 80 years of age. On that basis, age may be 
considered a modifying factor for HRQoL domain that will 
change after the procedure.
NYHA and Canadian Cardiovascular Society (CCS) 
class. There is no data on the influence of those factors 
on HRQoL change after pacemaker implantation. Obtained 
results show that NYHA class influences improvement in 
HRQoL domains, while the presence of symptoms of angina 
before implantation is associated with the lack of HRQoL 
improvement after pacemaker implantation.
Level of disability. The analysis of HRQoL change 
depending on the level of disability showed statistically 
significant reduction of S.D. among independently walking 
patients. This is the first publication to report such an 
association.
Level of care and social support. Caregivers play 
a great role in providing proper HRQoL. Some studies [25] 
indicate that patients who had been cared for by their 
spouses experience statistically significant improvement 
in HRQoL after cardiac pacemaker implantation compared 
to other patients.
It was shown that patients declaring high level of care 
and social support (defined as family care on a level that is 
expected by the patient) reported significant improvement 
in the domain of HRQoL related to S.D. after pacemaker 
implantation.
Physical activity. There are no analyses in the availab-
le literature regarding an association between physical 
activity and HRQoL among patients subject to constant 
cardiac pacing.
In our study, the analysis of HRQoL changes depending 
on declared physical activity showed improvement in the 
E.R. domain only among patients who had not previously 
declared physical activity. On the other hand, we noted 
greater improvement in sleep quality domain among pa-
tients declaring physical activity.
There were no significant changes in the assessment 
of global HRQoL. We observed, however, modification of 
HRQoL domains associated with physical activity.
One should keep in mind certain limitations of the 
above analysis — it was based on self-proclaimed intensity 
and regularity of physical activity reported by predominan-
tly elderly patients. It was not always possible to verify 
this data through the family or caregivers. It may be the 
source of error due to underestimation or overestimation 
of the level of physical activity by the patient. Verification 
of those parameters is difficult, if not impossible. In fact, 
the very awareness that the analysis of physical activity 
is being performed may motivate change (e.g. increase 
in activity) followed by restoration of old habits after the 
end of the study.
Diet. No analyses have been found to date regarding 
HRQoL change depending on diet. The obtained results 
indicate improvement in the study group with regard to 
S.D. among patients declaring change in diet following 
pacemaker implantation.
This analysis may be prone to error due to a small 
number of patients declaring change in nutritional 
habits.
Symptoms associated with arrhythmia and conduction 
disorders. There were previous reports [19, 25] that per-
ception of arrhythmia might be the main determinant of 
HRQoL both before and after pacemaker implantation.
In our study we analyzed the relationship between 
HRQoL and symptoms related to arrhythmia and con-
duction disorders. It was shown that sleep quality domain 
of HRQoL is significantly improved only among patients 
without Adams-Stokes syndrome.
Similar analyses were conducted by Benzer [19], 
although they involved a much smaller group of patients. 
Moreover, the data concerning symptoms were obtained 
indirectly from the European Pacemaker Patient Identi-
fication Card (in our study this data was collected from 
medical records and during detailed physical examination). 
Most importantly, patients identified by Benzer’s as having 
“syncope and dizziness”, constituted two separate groups 
in our study.
The lack of precise definition of a term “sensation of 
arrhythmia” (MAS, pre-MAS, other?) in the studies by Chen 
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and Chao [25] also made it difficult to compare between 
their results and that from our own study, where such 
a distinction — MAS, pre-MAS, other — was associated 
with great clinical value.
An unexpected result, such as lack of HRQoL improve-
ment in patients after syncope, may be explained by the 
fact that syncopal episodes are treated more seriously by 
both patients and doctors, usually resulting in fast-track 
diagnostics and immediate pacemaker implantation in 
case of syncope of arrhythmic origin with indications for 
cardiac stimulation. It may be expected that in such cases 
HRQoL is not significantly affected due to a short time 
between syncope and pacemaker implantation; thus, the 
lower increase in the HRQoL after implantation. Patients 
suffering from other symptoms, which recur and lead to 
significant drop in HRQoL, take more time before under-
going diagnostics.
Also, it should be considered whether presyncope 
episodes or other unpleasant symptoms experienced with 
consciousness might affect HRQoL to a much greater ex-
tent than short-lasting episodes of loss of consciousness 
accompanied by retrograde amnesia, especially if they are 
not associated with a serious trauma.
Summary and limitation of the study
It is worth emphasizing that the study included con-
secutive patients undergoing pacemaker implantation 
regardless of age or indications for pacing, and general 
NHP questionnaire — the shortest, most transparent 
and intelligible for the patient — was used for HRQoL 
assessment [2]. It seemed to be the reason for such 
a high percentage of patients (82%) who completed 
the study.
This is the only analysis to include such a broad range 
of factors potentially influencing the HRQoL. Previous re-
ports on the topic were very disappointing with regard to 
methodology, due to analyses limited to data contained 
in the European Pacemaker Patient Identification Card 
[19], or failure to include comorbidities other than car-
diovascular [18].
One should keep in mind local sociodemographic 
and cultural factors while analyzing HRQoL. The strong 
correlation between HRQoL and place of residence or BMI 
may be related to the aforementioned factors and may 
not be observed in other regions of the country, while the 
relationship between HRQoL and percentage of ventricular 
pacing may result from methodology of the study.
Further analyses are necessary to elucidate these 
uncertainties.
Conclusions
Association between change in HRQoL after pacemaker 
implantation with place of residence, patient BMI and 
percentage of ventricular pacing has been demonstrated. 
It was shown in the study group that improvement in HRQoL 
after pacemaker implantation involves mainly sleep disor-
ders and emotional reactions.
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Streszczenie
Wstęp. Jakość życia zależna od stanu zdrowia (HRQoL) po implantacji kardiostymulatora (PM) była przedmiotem wielu 
analiz, w których dominowała ocena zależności HRQoL od trybu stymulacji i wskazań do zabiegu. Czynniki te nie wyjaś-
niają jednak w pełni zmian HRQoL, co motywuje do poszukiwania innych uwarunkowań zmiany HRQoL po implantacji 
PM.
Materiał i metody. Przeprowadzono jednoośrodkowe, prospektywne badanie obserwacyjne u 101 dorosłych pacjentów, 
którym bez powikłań implantowano PM. Pacjentów ankietowano 2-krotnie — w okresie okołozabiegowym i na zakoń-
czenie 18-miesięcznej obserwacji (FU). Jakość życia zależną od stanu zdrowia oceniano za pomocą kwestionariusza 
Nottingham Health Profile. Pełen protokół badania ukończyło 83 pacjentów. W tej grupie przeprowadzono analizę porów-
nawczą (okres okołozabiegowy v. FU) w celu pomiaru związku między zmianą HRQoL a: płcią, miejscem zamieszkania, 
poziomem niepełnosprawności, aktywnością fizyczną, poziomem opieki i wsparcia, wskaźnikiem masy ciała (BMI), dietą, 
odsetkiem stymulacji przedsionkowej i komorowej (Ap i Vp), objawami związanymi z zaburzeniami rytmu i przewodzenia, 
zaawansowaniem choroby wieńcowej i niewydolności serca.
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Wyniki. Poprawa HRQoL po implantacji PM nastąpiła u mieszkańców wsi, osób otyłych i tych z Vp ponad 79%. W całej 
badanej grupie znaczną poprawę obserwowano w zakresie dwóch domen HRQoL — reakcji emocjonalnych (E.R.) i zabu-
rzeń snu (S.D.). Analizując poszczególne domeny HRQoL (energia, ból, wyobcowanie społeczne, E.R.S.D. ograniczenia 
ruchowe), poprawę obserwowano u kobiet, osób zdolnych do samodzielnego poruszania się, osób z wysokim poziomem 
opieki i wsparcia, oraz tych, którzy po implantacji PM zmienili nawyki żywieniowe, a także tych, którzy nie doświadczyli 
omdlenia i dławicy piersiowej. Wiek i BMI zidentyfikowano jako czynniki zmieniające domenę HRQoL ulegającą poprawie 
po implantacji.
Wnioski. Poprawa HRQoL po implantacji PM wydaje się związana głównie z S.D. i E.R. Ważnymi czynnikami wpływającymi 
na zmianę HRQoL są miejsce zamieszkania, BMI i odsetek Vp. Wpływ implantacji PM na HRQoL wymaga dalszych badań.
Słowa kluczowe: jakość życia uwarunkowana stanem zdrowia, HRQoL, PM, QoL, NHP
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References
1. Broda G. Jakość życia — ważny pomiar zdrowia. Kardiol Pol. 2009; 
67(10): 1086–1087.
2. Wrześniewski K. Jak badać jakość życia pacjentów kardiologicznych? 
Kardiol Pol. 2009; 67(7): 790–794.
3. Kawecka-Jaszcz K, Klocek M, Tobiasz-Adamczyk B. Jakość życia w cho-
robach układu sercowo naczyniowego. Metody pomiaru i znaczenie 
kliniczne, Termedia Wydawnictwa Medyczne, Poznań 2006.
4. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical 
outcomes in elderly patients treated with ventricular pacing as compa-
red with dual-chamber pacing. Pacemaker Selection in the Elderly In-
vestigators. N Engl J Med. 1998; 338(16): 1097–1104, doi: 10.1056/
NEJM199804163381602, indexed in Pubmed: 9545357.
5. Newman D, Lau C, Tang ASL, et al. CTOPP Investigators. Effect of pa-
cing mode on health-related quality of life in the Canadian Trial of Phy-
siologic Pacing. Am Heart J. 2003; 145(3): 430–437, doi: 10.1067/
mhj.2003.167, indexed in Pubmed: 12660665.
6. GRIBBIN G, KENNY R, MCCUE P, et al. Individualised quality of life 
after pacing. Does mode matter? Europace. 2004; 6(6): 552–560, 
doi: 10.1016/j.eupc.2004.07.011.
7. Linde-Edelstam C, Nordlander R, Unden AL, et al. Quality-of-life in 
patients treated with atrioventricular synchronous pacing compared 
to rate modulated ventricular pacing: a long-term, double-blind, cros-
sover study. Pacing Clin Electrophysiol. 1992; 15(10): 1467–1476, 
doi: 10.1111/j.1540-8159.1992.tb02920.x.
8. Lau CP, Rushby J, Leigh-Jones M, et al. Symptomatology and quality 
of life in patients with rate-responsive pacemakers: a double-blind, 
randomized, crossover study. Clin Cardiol. 1989; 12(9): 505–512, 
indexed in Pubmed: 2791372.
9. Oto MA, Müderrisoglu H, Ozin MB, et al. Quality of life in patients 
with rate responsive pacemakers: a randomized, cross-over study. 
Pacing Clin Electrophysiol. 1991; 14(5 Pt 1): 800–806, indexed in 
Pubmed: 1712957.
10. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing 
versus ventricular pacing on the risk of stroke and death due to 
cardiovascular causes. Canadian Trial of Physiologic Pacing Investi-
gators. N Engl J Med. 2000; 342(19): 1385–1391, doi: 10.1056/
NEJM200005113421902, indexed in Pubmed: 10805823.
11. Lamas GA, Lee KL, Sweeney MO, et al. Mode Selection Trial in Sinus-
-Node Dysfunction. Ventricular pacing or dual-chamber pacing for 
sinus-node dysfunction. N Engl J Med. 2002; 346(24): 1854–1862, 
doi: 10.1056/NEJMoa013040, indexed in Pubmed: 12063369.
12. Menozzi C, Brignole M, Moracchini PV, et al. Intrapatient comparison 
between chronic VVIR and DDD pacing in patients affected by high de-
gree AV block without heart failure. Pacing Clin Electrophysiol. 1990; 
13(12 Pt 2): 1816–1822, indexed in Pubmed: 1704547.
13. Hargreaves MR, Channon KM, Cripps TR, et al. Comparison of 
dual chamber and ventricular rate responsive pacing in patients 
over 75 with complete heart block. Heart. 1995; 74(4): 397–402, 
doi: 10.1136/hrt.74.4.397.
14. Linde-Edelstam C, Nordlander R, Pehrsson SK, et al. A double-blind 
study of submaximal exercise tolerance and variation in paced rate 
in atrial synchronous compared to activity sensor modulated ven-
tricular pacing. Pacing Clin Electrophysiol . 1992; 15(6): 905–915, 
doi: 10.1111/j.1540-8159.1992.tb03081.x.
15. Oldroyd KG, Rae AP, Carter R, et al. Double blind crossover compari-
son of the effects of dual chamber pacing (DDD) and ventricular rate 
adaptive (VVIR) pacing on neuroendocrine variables, exercise perfor-
mance, and symptoms in complete heart block. Heart. 1991; 65(4): 
188–193, doi: 10.1136/hrt.65.4.188.
16. Deharo JC, Badier M, Thirion X, et al. A randomized, single-blind 
crossover comparison of the effects of chronic DDD and dual sensor 
VVIR pacing mode on quality-of-life and cardiopulmonary performan-
ce in complete heart block. Pacing Clin Electrophysiol. 1996; 19(9): 
1320–1326, indexed in Pubmed: 8880795.
17. van Eck JW, van Hemel NM, van den Bos A, et al. Predictors of impro-
ved quality of life 1 year after pacemaker implantation. Am Heart J. 
2008; 156(3): 491–497, doi: 10.1016/j.ahj.2008.04.029, indexed 
in Pubmed: 18760131.
18. Udo EO, van Hemel NM, Zuithoff NPA, et al. Long term quality-of-life 
in patients with bradycardia pacemaker implantation. Int J Cardiol. 
2013; 168(3): 2159–2163, doi: 10.1016/j.ijcard.2013.01.253, inde-
xed in Pubmed: 23453871.
19. Benzer W, Oldridge N, Anelli Monti M, et al. Clinical predictors of 
health-related quality of life after pacemaker implantation. Wien Klin 
12
Folia Cardiologica 2019, vol. 14, no. 1
www.journals.viamedica.pl/folia_cardiologica
Wochenschr. 2006; 118(23-24): 739–743, doi: 10.1007/s00508-
006-0714-y, indexed in Pubmed: 17186169.
20. Fleischmann KE, Orav EJ, Lamas GA, et al. Pacemaker implantation 
and quality of life in the Mode Selection Trial (MOST). Heart Rhythm. 
2006; 3(6): 653–659, doi: 10.1016/j.hrthm.2006.02.1031, indexed 
in Pubmed: 16731465.
21. Kostkiewicz M. Odległa ocena kliniczna, elektrokardiograficzna oraz ja-
kość życia pacjentów leczonych implantacją kardiostymulatora. Praca 
doktorska. Uniwersytet Jagielloński, Kraków 2013.
22. van Hemel NM, Holwerda K, Slegers P, et al. The contribution of rate 
adaptive pacing with single or dual sensors to health-related quality 
of life. EP Europace. 2007; 9(4): 233–238, doi: 10.1093/europace/
eum021.
23. Kushner RF, Foster G. Obesity and quality of life. Nutrition. 2000; 
16(10): 947–952, doi: 10.1016/s0899-9007(00)00404-4.
24. Oliveira BG, Velasquez-Melendez G, Rincón LG, et al. Health-
-related quality of life in Brazilian pacemaker patients. Pacing Clin 
Electrophysiol. 2008; 31(9): 1178–1183, doi: 10.1111/j.1540-
-8159.2008.01159.x, indexed in Pubmed: 18834470.
25. Chen HM, Chao YF. Change in quality of life in patients with permanent 
cardiac pacemakers: a six-month follow-up study. J Nurs Res. 2002; 
10(2): 143–150, indexed in Pubmed: 12119599.
